Solventum (SOLV) Stock Forecast & Price Target

$66.83 +0.03 (+0.04%)

(As of 12/20/2024 05:31 PM ET)

Solventum - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 11 Analyst Ratings

Sell
1

Hold
9

Buy
1

Based on 11 Wall Street analysts who have issued ratings for Solventum in the last 12 months, the stock has a consensus rating of "Hold." Out of the 11 analysts, 1 has given a sell rating, 9 have given a hold rating, and 1 has given a buy rating for SOLV.

Consensus Price Target

$68.29
2.18% Upside

According to the 11 analysts' twelve-month price targets for Solventum, the average price target is $68.29. The highest price target for SOLV is $82.00, while the lowest price target for SOLV is $54.00. The average price target represents a forecasted upside of 2.18% from the current price of $66.83.

Get the Latest News and Ratings for SOLV and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Solventum and its competitors.

SOLV Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	1 Buy rating(s)	1 Buy rating(s)	0 Buy rating(s)	N/A
Hold	9 Hold rating(s)	8 Hold rating(s)	6 Hold rating(s)	N/A
Sell	1 Sell rating(s)	1 Sell rating(s)	1 Sell rating(s)	N/A
Consensus Price Target	$68.29	$68.00	$58.25	N/A
Forecasted Upside	2.18% Upside	-2.34% Downside	-16.73% Downside	N/A
Consensus Rating	Hold	Hold	Reduce	N/A

Is Starlink Set For The Largest IPO In History? (Ad)

He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again with Tesla… which is up more than 19,500% since 2010. For perspective, that turns $100 invested into almost $20,000!

Click here now for the urgent details.

SOLV Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

SOLV Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Solventum Stock vs. The Competition

Type	Solventum	Medical Companies	S&P 500
Consensus Rating Score	2.00	2.81	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	2.18% Upside	25,828.59% Upside	14.53% Upside
News Sentiment Rating	Positive News See Recent SOLV News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/4/2024	Mizuho 3 of 5 stars	S. Valiquette Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral	$70.00	-1.06%
11/11/2024	Morgan Stanley 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$60.00 ➝ $73.00	+0.79%
11/8/2024	Piper Sandler 2 of 5 stars	J. Bednar Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Neutral ➝ Neutral	$71.00 ➝ $75.00	-0.09%
10/8/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$82.00	+23.70%
9/26/2024	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Senyek Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Peer Perform
9/5/2024	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Zimmerman Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Neutral
8/12/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sell ➝ Sell	$48.00 ➝ $54.00	-6.56%
8/9/2024	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Equal Weight ➝ Equal Weight	$69.00 ➝ $64.00	+5.66%
6/25/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Neutral ➝ Neutral	$70.00 ➝ $60.00	+17.26%
6/24/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold
4/2/2024	Edward Jones Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Hold

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Sunday at 12:04 AM ET.

SOLV Forecast - Frequently Asked Questions

: According to the research reports of 11 Wall Street equities research analysts, the average twelve-month stock price forecast for Solventum is $68.29, with a high forecast of $82.00 and a low forecast of $54.00.
: 11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Solventum in the last year. There is currently 1 sell rating, 9 hold ratings and 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "hold" SOLV shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in SOLV, but not buy additional shares or sell existing shares.
: According to analysts, Solventum's stock has a predicted upside of 2.18% based on their 12-month stock forecasts.
: Solventum has been rated by research analysts at Mizuho, Morgan Stanley, Piper Sandler, Stifel Nicolaus, and Wolfe Research in the past 90 days.
: Analysts like Solventum less than other "medical" companies. The consensus rating for Solventum is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how SOLV compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

First JFK… next Elon? (Ad)

Today, I have another controversial prediction. One which I will take no pleasure in seeing come true. See, even with President Trump returning as the leader of our free country, I believe Elon Musk is in mortal danger.

I share with you in this special investigative documentary.

This page (NYSE:SOLV) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Solventum (SOLV) Stock Forecast & Price Target